For COVID-19 vaccine updates, please review our information guide and sign up for Connect. Continue your routine care with us by scheduling an in-person appointment or Video Visit.
Department of Anesthesiology
Author Title Type [ Year(Desc)]
Filters: Author is Lien, Cynthia A  [Clear All Filters]
2002
Lien CA.  2002.  Regional versus general anesthesia for hip surgery in older patients: does the choice affect patient outcome? J Am Geriatr Soc. 50(1):191-4.
2003
Suzuki T, Lien CA, Belmont MR, Tjan J, Savarese JJ.  2003.  Edrophonium effectively antagonizes neuromuscular block at the laryngeal adductors induced by rapacuronium, rocuronium and cisatracurium, but not mivacurium.. Can J Anaesth. 50(9):879-85.
2004
Belmont MR, Lien CA, Tjan J, Bradley E, Stein B, Patel SS, Savarese JJ.  2004.  Clinical pharmacology of GW280430A in humans.. Anesthesiology. 100(4):768-73.
Mack PFogarty, Perrine K, Kobylarz E, Schwartz TH, Lien CA.  2004.  Dexmedetomidine and neurocognitive testing in awake craniotomy.. J Neurosurg Anesthesiol. 16(1):20-5.
Naguib M, Lien CA, Aker J, Eliazo R.  2004.  Posttetanic potentiation and fade in the response to tetanic and train-of-four stimulation during succinylcholine-induced block.. Anesth Analg. 98(6):1686-91,tableofcontents.
Pryor KO, Fahey TJ, Lien CA, Goldstein PA.  2004.  Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial.. JAMA. 291(1):79-87.
2005
Lien CA, Belmont MR, Heerdt PM.  2005.  GW280430A: pharmacodynamics and potential adverse effects.. Anesthesiology. 102(4):861-2;authorreply862-3.
2006
Pryor KO, Lien CA, Fahey TJ, Goldstein PA.  2006.  Supplemental oxygen and risk of surgical wound infection.. JAMA. 295(14):1642;authorreply1642-3.
2009
Lien CA, Savard P, Belmont M, Sunaga H, Savarese JJ.  2009.  Fumarates: unique nondepolarizing neuromuscular blocking agents that are antagonized by cysteine.. J Crit Care. 24(1):50-7.
2010
Lien CA.  2010.  Neostigmine: how much is necessary for patients who receive a nondepolarizing neuromuscular blocking agent? Anesthesiology. 112(1):16-8.
Naguib M, Kopman AF, Lien CA, Hunter JM, Lopez A, Brull SJ.  2010.  A survey of current management of neuromuscular block in the United States and Europe.. Anesth Analg. 111(1):110-9.
2012
Lien CA.  2012.  A need to establish programs to detect and prevent drug diversion.. Mayo Clin Proc. 87(7):607-9.
2014
Lien CA, Kopman AF.  2014.  Current recommendations for monitoring depth of neuromuscular blockade.. Curr Opin Anaesthesiol. 27(6):616-22.
2015
Sun H, Culley DJ, Lien CA, Kitchener DL, Harman AE, Warner DO.  2015.  Predictors of performance on the Maintenance of Certification in Anesthesiology Program® (MOCA®) examination.. J Clin Anesth. 27(1):1-6.
2016
Heerdt PM, Sunaga H, Owen JS, Murrell MT, Malhotra JK, Godfrey D, Steinkamp M, Savard P, Savarese JJ, Lien CA.  2016.  Dose-response and Cardiopulmonary Side Effects of the Novel Neuromuscular-blocking Drug CW002 in Man.. Anesthesiology. 125(6):1136-1143.
Fleischut PM, Eskreis-Winkler JM, Gaber-Baylis LK, Giambrone GP, Wu X, Sun X, Lien CA, Faggiani SL, Dutton RP, Memtsoudis SG.  2016.  Provider Board Certification Status and Practice Patterns in Total Knee Arthroplasty.. Acad Med. 91(1):79-86.
2018
Bustillo MA, Lien CA, Mack PFogarty, Kopman DJ, Safavynia SA, Rubin L, Stein D, Härtl R, Stieg PE, R Hernandez N et al..  2018.  Optimizing patient access during an emergency while using intraoperative computed tomography.. World Neurosurg.
Kaullen JD, Owen JS, Brouwer KLR, Heerdt PM, Lien CA, Savarese JJ, Schmith VD.  2018.  Pharmacokinetic/Pharmacodynamic Model of CW002, an Investigational Intermediate Neuromuscular Blocking Agent, in Healthy Volunteers.. Anesthesiology. 128(6):1107-1116.